Sustained mTOR hyperactivation contributes to obesity, insulin resistance, neurodegeneration, and cancer, while AMPK activation counterbalances these effects by restoring cellular energy balance and enhancing metabolic resilience. This evidence concerns the gene PRKAA2 and Insulin resistance.